2 sources • 4 verified points
Coverage of new weight-loss drugs in development and trials
The sources cover new weight-loss drugs, including retatrutide and CagriSema, in addition to a drug from Amgen and GLP-1 medications. The available sources contain only short headlines without details or results.
AI-written summary of 2 sources; every verified point is backed by a verbatim quote. How Iyan works
- Retatrutide and CagriSema were mentioned among new weight-loss drugs in 2026.
«new weight loss drugs 2026 retatrutide cagrisema»
www.polskieradio.pl - Retatrutide was described as the most potent weight-loss drug in clinical development.
«retatrutide most powerful weight loss drug clinical development»
www.polskieradio.pl - One report covered an update on a trial of Amgen's weight-loss drug.
«amgen weight loss drug trial update»
www.polskieradio.pl - One headline pointed to a new drug that outperforms Ozempic.
«new weight loss drug outperforming ozempic»
Meteo.gr
Sourceswww.polskieradio.plMeteo.grMeteo.grMeteo.grwww.polskieradio.plMeteo.grwww.polskieradio.plwww.polskieradio.pl
Follow this development in Iyan
Iyan — See it for yourself. What changed in your world today, why it matters, and how we know.
How it works • Privacy • Terms